Author： Sproule B.
Publisher： Adis International
ISSN： 0312-5963
Source： Clinical Pharmacokinetics, Vol.41, Iss.9, 2002-01, pp. : 639-660
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is Lithium Still the Maintenance Treatment of Choice for Bipolar Disorder?
CNS Drugs, Vol. 14, Iss. 2, 2000-08 ,pp. :
Access to resources
Recommend
Quetiapine: single-drug therapy for bipolar disorder?
Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. :
Hepatotoxicity with Thiazolidinediones: Is it a Class Effect?
By Scheen A.J.
Drug Safety, Vol. 24, Iss. 12, 2001-01 ,pp. :
NSAIDs and the risk of CV events: is there a class effect?
Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. :